ArticleEClinicalMedicine2025

Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trial.

Shida Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.